Today CHA Hollywood Presbyterian Medical Center (CHA HPMC), a hospital that is a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, announced the opening of a state-of-the-art ophthalmic surgery suite as part of the hospital’s Southern California Eye Institute. The new hospital-based ophthalmic operating room is the first hospital-based facility dedicated to eye surgery in the Los Angeles area.
Regarding the hospital-based ophthalmic operating room, Rohit Varma, MD, MPH, director of Southern California Eye Institute said, “As a team, we’ve taken bold steps to create a premier surgical suite that will offer the latest advancements and technology while focusing on patient experience and outcomes.”
The surgical suite is designed to create a seamless experience for patients and families. The operating rooms will be fully equipped with new state-of-the-art laser only cataract technology by early 2020, which will enable more precise intraocular implant measurements. The dedicated operating room will also have its own scheduling system, enabling convenient, faster scheduling for patients and community ophthalmologists.
“We’re very excited to finally have two ophthalmology-exclusive operating rooms available for patients and healthcare providers,” said Jacob Reznik, MD, a cataract and refractive surgery specialist who will oversee the surgery suite. “We will work closely with our colleagues and CHA HPMC physicians to continue building upon this center of excellence in ophthalmic surgery.”
With the laser-assisted cataract surgery technology, ophthalmic surgeons will be able to perform minimally invasive surgeries. New suite will also enable the performance of advanced glaucoma surgical tubes and trabeculectomies including XenGel implantation, microincisional glaucoma surgery including iStent, Hydrus, Kahook dual-blade (KDB) OMNI, and micropulse laser. Advanced retinal procedures will include small incision sutureless vitrectomy, epiretinal membrane surgery, and advanced diabetic disease procedures. Innovative oculofacial plastic surgery procedures will include ptosis (droopy eyelid), blepharoplasty (excess skin), ectropion (eyelid turning out), entropion (eyelid turning in), eyelid tumors, thyroid eye disease, tearing problems, facial trauma, and orbital tumors. The cutting edge therapy using the newest advanced technology will reduce surgical times and enable quick recovery for patients to return to their daily activities quickly.
“We are on a continual mission to create better ways — and embarked on a $400 million master plan slated for completion by 2021. We are making huge investments in the facility to develop Centers of Excellence, innovative technology, and people to better serve our Los Angeles community and be the medical center of the future,” said Robert Allen, CHA Hollywood Presbyterian Medical Center president and chief executive officer.